39 results
Thumbnail

D2.44 - Subjective assessment of sleep quality in adult patients with hereditary angioedema

Thumbnail

D2.47 - Unmasking Melkersson-Rosenthal Syndrome: Diagnostic Challenges in a Patinent Pressenting With Angioedema

Thumbnail

D2.57 - Evidence of Lower Airway Inflammation in Children with Allergic Rhinitis without Asthma

Thumbnail

D2.43 - Hereditary Angioedema Can Hit at Any Age: A Case Report in Egypt

Thumbnail

D2.45 - Fixed Drug Eruption Due to Fenofibrate Hypersensitivity

Thumbnail

D2.46 - Patient with the overlap of Hereditary angioedema and Chronic spontaneous urticaria

Thumbnail

D2.48 - When Treatment Becomes the Cause: Allergic Contact Dermatitis to Topical Corticosteroids

Thumbnail

D2.49 - Quality of Life and Affecting Factors in Patients with Chronic Urticaria

Thumbnail

D2.50 - When Angioedema Is Not Angioedema: Orofacial Sarcoidosis Mimicking Refractory Facial Swelling

Thumbnail

D2.51 - Contact dermatitis due to continuous glucose monitoring sensors: limitations of standard patch testing

Thumbnail

D2.53 - Impact of Smoking on the Clinical and Allergological Profile of Allergic Contact Dermatitis: An 8-Year Analytical Study

Thumbnail

D2.54 - Correlation Between IgE Anti-Thyroid Peroxidase And Chronic Spontaneous Urticaria

Thumbnail

D2.55 - Allergic contact dermatitis and cross-sensitization after laser-assisted 5-aminolevulinic acid PDT

Thumbnail

D2.56 - Regionally Adapted Patch Test Panels Improve Diagnostic Resolution by Revealing Hidden Polysensitization in Allergic Contact Dermatitis

Thumbnail

D3.440 - Long-Term Efficacy and Safety of Donidalorsen for Hereditary Angioedema Among Patients in Europe: A Regional Analysis of the OASISplus Study

Thumbnail

D3.441 - Switching to Donidalorsen for Hereditary Angioedema: 1-Year Results From the Phase 3 OASISplus Study

Thumbnail

D3.444 - Efficacy and Safety of Donidalorsen for Patients With Hereditary Angioedema in Europe Who Switched From Prior Long-Term Prophylaxis: Results From the OASISplus Study

Thumbnail

D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial

Thumbnail

D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial

Thumbnail

D3.438 - Clinical outcomes with navenibart according to baseline attack rate, body mass index, and age: results of the ALPHA-STAR trial